Cargando…
Increased Diacylglycerols Characterize Hepatic Lipid Changes in Progression of Human Nonalcoholic Fatty Liver Disease; Comparison to a Murine Model
BACKGROUND AND AIMS: The spectrum of nonalcoholic fatty liver disease (NAFLD) includes steatosis, nonalcoholic steatohepatitis (NASH), and progression to cirrhosis. While differences in liver lipids between disease states have been reported, precise composition of phospholipids and diacylglycerols (...
Autores principales: | Gorden, D. Lee, Ivanova, Pavlina T., Myers, David S., McIntyre, J. Oliver, VanSaun, Michael N., Wright, J. Kelly, Matrisian, Lynn M., Brown, H. Alex |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3153459/ https://www.ncbi.nlm.nih.gov/pubmed/21857953 http://dx.doi.org/10.1371/journal.pone.0022775 |
Ejemplares similares
-
Hepatocellular Proliferation Correlates with Inflammatory Cell and Cytokine Changes in a Murine Model of Nonalchoholic Fatty Liver Disease
por: VanSaun, Michael N., et al.
Publicado: (2013) -
Modulation of the Leptin Receptor Mediates Tumor Growth and Migration of Pancreatic Cancer Cells
por: Mendonsa, Alisha M., et al.
Publicado: (2015) -
Host and tumor derived MMP13 regulate extravasation and establishment of colorectal metastases in the liver
por: Mendonsa, Alisha M, et al.
Publicado: (2015) -
Adiponectin receptor agonists inhibit leptin induced pSTAT3 and in vivo pancreatic tumor growth
por: Messaggio, Fanuel, et al.
Publicado: (2017) -
Hepatic Stearoyl-CoA Desaturase (SCD)-1 Activity and Diacylglycerol but Not Ceramide Concentrations Are Increased in the Nonalcoholic Human Fatty Liver
por: Kotronen, Anna, et al.
Publicado: (2009)